| 1 | Impact of antiplatelet therapy on the hemostatic efficacy of platelet-targeted FVIII gene therapy in hemophilia A mice. (Yu H, Schroeder JA, Mattson JG, Gao C, Shi Q) Blood Adv 2026 Mar 24;10(6):1883-1896 |
| 1 | Preclinical safety and bleeding evaluation in swine for a small interfering RNA-lipid nanoparticle that prevents excess fibrinogen synthesis. (Seadler MS, Ferraresso F, Turner HM, Ketelboeter LM, Zhang Y, Badior K, Hayssen WG, Chen T, Haugen AL, Cau MF, Robertson M, Skaer C, Bansal M, Murphy PB, de Moya M, Dyer MR, Kastrup CJ) J Thromb Haemost 2026 Feb;24(2):508-519 1 Citation |
| 1 | Effect of age on ISTH-BAT scores and low VWF diagnosis in the Zimmerman Program. (Atiq F, Christopherson PA, Doherty D, Hulshof AM, Haberichter SL, Flood VH, Lavin M, O'Connell NM, Ryan K, Byrne M, Grabell J, James PD, Lillicrap D, Montgomery RR, Di Paola J, O'Donnell JS) Blood Adv 2025 Oct 14;9(19):4780-4789 5 Citations |
| 1 | American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients. (Monagle P, Azzam M, Bercovitz R, Betensky M, Bhat R, Biss T, Branchford B, Brandão LR, Chan AKC, Faustino EVS, Jaffray J, Jones S, Kawtharany H, Kerlin BA, Kucine N, Kumar R, Male C, Pelland-Marcotte MC, Raffini L, Raulji C, Sartain SE, Takemoto CM, Tarango C, van Ommen CH, Velez MC, Vesely SK, Wiernikowski J, Williams S, Wilson HP, Woods G, Zia A, Mustafa RA) Blood Adv 2025 May 27;9(10):2587-2636 26 Citations |
| 2 | PACSIN2 regulates platelet integrin β1 hemostatic function. (Biswas R, Boyd EK, Eaton N, Steenackers A, Schulte ML, Reusswig F, Yu H, Drew C, Kahr WHA, Shi Q, Plomann M, Hoffmeister KM, Falet H) J Thromb Haemost 2023 Dec;21(12):3619-3632 1 Citation |
| 1 | Platelet-targeted gene therapy induces immune tolerance in hemophilia and beyond. (Kumar S, Schroeder JA, Shi Q) J Thromb Haemost 2024 Jan;22(1):23-34 10 Citations |
| 1 | Self-propelling thrombin powder enables hemostasis with no observable recurrent bleeding or thrombosis over 3 days in a porcine model of upper GI bleeding. (Ali-Mohamad N, Cau MF, Zenova V, Baylis JR, Beckett A, McFadden A, Donnellan F, Kastrup CJ) Gastrointest Endosc 2023 Aug;98(2):245-248 9 Citations |
| 1 | Variability in International Society on Thrombosis and Haemostasis-Scientific and Standardization Committee endorsed Bleeding Assessment Tool (ISTH-BAT) score with normal aging in healthy females: contributory factors and clinical significance. (Doherty D, Grabell J, Christopherson PA, Montgomery RR, Coller BS, Lavin M, O'Donnell JS, James PD, Zimmerman Program Investigators) J Thromb Haemost 2023 Apr;21(4):880-886 32 Citations |
| 1 | Hemophilia a patients with inhibitors: Mechanistic insights and novel therapeutic implications. (Luo L, Zheng Q, Chen Z, Huang M, Fu L, Hu J, Shi Q, Chen Y) Front Immunol 2022;13:1019275 17 Citations |
| 1 | ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation. (Deconinck SJ, Nix C, Barth S, Bennek-Schöpping E, Rauch A, Schelpe AS, Roose E, Feys HB, Pareyn I, Vandenbulcke A, Muia J, Vandenbriele C, Susen S, Meyns B, Tersteeg C, Jacobs S, De Meyer SF, Vanhoorelbeke K) J Thromb Haemost 2022 Dec;20(12):2797-2809 13 Citations |
| 1 | Gelatin sponge to close a tract after large-bore transhepatic access: tips for success. (Mohammad Nijres B, Justino H, Law I, Aldoss O) Cardiol Young 2023 May;33(5):803-805 1 Citation |
| 1 | Liquid-infused microstructured bioadhesives halt non-compressible hemorrhage. (Bao G, Gao Q, Cau M, Ali-Mohamad N, Strong M, Jiang S, Yang Z, Valiei A, Ma Z, Amabili M, Gao ZH, Mongeau L, Kastrup C, Li J) Nat Commun 2022 Aug 26;13(1):5035 93 Citations |
| 1 | Practical considerations and consensus opinion for children's hospital-based inpatient hemostasis and thrombosis (HAT) consultative services: Communication from the ISTH SSC Subcommittee on Pediatric/Neonatal Thrombosis and Hemostasis. (Woods GM, Raffini L, Brandão LR, Jaffray J, Branchford BR, Ng CJ, Sartain SE, Pak J, Male C, Zia A, Rizzi M, Sirachainan N, Faustino EVS, Carpenter SL, Goldenberg NA) J Thromb Haemost 2022 Sep;20(9):2151-2158 |
| 1 | Hypofibrinogenemia with preserved hemostasis and protection from thrombosis in mice with an Fga truncation mutation. (Hur WS, Paul DS, Bouck EG, Negrón OA, Mwiza JM, Poole LG, Cline-Fedewa HM, Clark EG, Juang LJ, Leung J, Kastrup CJ, Ugarova TP, Wolberg AS, Luyendyk JP, Bergmeier W, Flick MJ) Blood 2022 Mar 03;139(9):1374-1388 24 Citations |
| 1 | Consensus Statement: Hemostasis Trial Outcomes in Cardiac Surgery and Mechanical Support. (Levy JH, Faraoni D, Almond CS, Baumann-Kreuziger L, Bembea MM, Connors JM, Dalton HJ, Davies R, Dumont LJ, Griselli M, Karkouti K, Massicotte MP, Teruya J, Thiagarajan RR, Spinella PC, Steiner ME) Ann Thorac Surg 2022 Mar;113(3):1026-1035 23 Citations |
| 1 | Surgical management of patients with von Willebrand disease: summary of 2 systematic reviews of the literature. (Brignardello-Petersen R, El Alayli A, Husainat N, Kalot M, Shahid S, Aljabirii Y, Britt A, Alturkmani H, El-Khechen H, Motaghi S, Roller J, Dimassi A, Abughanimeh O, Madoukh B, Arapshian A, Grow JM, Kouides P, Laffan M, Leebeek FWG, O'Brien SH, Tosetto A, James PD, Connell NT, Flood V, Mustafa RA) Blood Adv 2022 Jan 11;6(1):121-128 19 Citations |
| 2 | Recombinant activated factor VII for hemostasis in patients undergoing complex ascending aortic surgery: A single-center, single-surgeon retrospective analysis. (Hang D, Koss K, Rokkas CK, Pagel PS) J Card Surg 2021 Dec;36(12):4558-4563 4 Citations |
| 1 | Bleeding diathesis in mice lacking JAK2 in platelets. (Eaton N, Subramaniam S, Schulte ML, Drew C, Jakab D, Haberichter SL, Weiler H, Falet H) Blood Adv 2021 Aug 10;5(15):2969-2981 |
| 1 | Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies-TacDOAC registry: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy. (Wang TF, Baumann Kreuziger L, Leader A, Spectre G, Lim MY, Gahagan A, Gangaraju R, Sanfilippo KM, Mallick R, Zwicker JI, Carrier M) J Thromb Haemost 2021 Aug;19(8):2068-2081 36 Citations |
| 1 | Emerging gene therapies for enhancing the hemostatic potential of platelets. (Leung J, Cau MF, Kastrup CJ) Transfusion 2021 Jul;61 Suppl 1:S275-S285 4 Citations |
| 3 | Thromboelastometry assessment of hemostatic properties in various murine models with coagulopathy and the effect of factor VIII therapeutics. (Schroeder JA, Kuether EA, Fang J, Jing W, Weiler H, Wilcox DA, Montgomery RR, Shi Q) J Thromb Haemost 2021 Oct;19(10):2417-2427 7 Citations |
| 1 | International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis. (van Ommen CH, Albisetti M, Bhatt M, Bonduel M, Branchford B, Chalmers E, Chan A, Goldenberg NA, Holzhauer S, Monagle P, Nowak-Göttl U, Revel-Vilk S, Sciuccatie G, Sirachainan N, Male C, Subcommittee on Pediatric, Neonatal Thrombosis, Hemostasis) J Thromb Haemost 2021 Apr;19(4):1123-1129 30 Citations |
| 1 | ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. (James PD, Connell NT, Ameer B, Di Paola J, Eikenboom J, Giraud N, Haberichter S, Jacobs-Pratt V, Konkle B, McLintock C, McRae S, R Montgomery R, O'Donnell JS, Scappe N, Sidonio R, Flood VH, Husainat N, Kalot MA, Mustafa RA) Blood Adv 2021 Jan 12;5(1):280-300 453 Citations |
| 1 | ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease. (Connell NT, Flood VH, Brignardello-Petersen R, Abdul-Kadir R, Arapshian A, Couper S, Grow JM, Kouides P, Laffan M, Lavin M, Leebeek FWG, O'Brien SH, Ozelo MC, Tosetto A, Weyand AC, James PD, Kalot MA, Husainat N, Mustafa RA) Blood Adv 2021 Jan 12;5(1):301-325 304 Citations |
| 1 | A microfluidic analysis of thrombus formation in reconstituted whole blood samples comparing spray-dried plasma versus fresh frozen plasma. (Bercovitz RS, Drew CS, Bushee CL, Popovsky MA, Friedman KD, Anani WQ) Vox Sang 2021 May;116(5):540-546 4 Citations |
| 1 | The adhesion of clots in wounds contributes to hemostasis and can be enhanced by coagulation factor XIII. (Chan KYT, Yong ASM, Wang X, Ringgold KM, St John AE, Baylis JR, White NJ, Kastrup CJ) Sci Rep 2020 Nov 18;10(1):20116 17 Citations |
| 1 | Platelet-Targeted FVIII Gene Therapy Restores Hemostasis and Induces Immune Tolerance for Hemophilia A. (Cai Y, Shi Q) Front Immunol 2020;11:964 7 Citations |
| 1 | Coagulation factor XII contributes to hemostasis when activated by soil in wounds. (Juang LJ, Mazinani N, Novakowski SK, Prowse ENP, Haulena M, Gailani D, Lavkulich LM, Kastrup CJ) Blood Adv 2020 Apr 28;4(8):1737-1745 40 Citations |
| 1 | microRNAs involved in T-cell development, selection, activation, and hemostasis. (Emamgolizadeh Gurt Tapeh B, Mosayyebi B, Samei M, Beyrampour Basmenj H, Mohammadi A, Alivand MR, Hassanpour P, Solali S) J Cell Physiol 2020 Nov;235(11):8461-8471 17 Citations |
| 1 | Adequacy of hemostatic resuscitation improves therapeutic efficacy of recombinant activated factor VII and reduces reexploration rate for bleeding in postoperative cardiac surgery patients with refractory hemorrhage. (Feih JT, Juul JJ, G Rinka JR, Baumann Kreuziger LM, Pagel PS, Tawil JN) Ann Card Anaesth 2019;22(4):388-393 5 Citations |
| 1 | Dynamin 2 is required for GPVI signaling and platelet hemostatic function in mice. (Eaton N, Drew C, Wieser J, Munday AD, Falet H) Haematologica 2020 May;105(5):1414-1423 8 Citations |
| 1 | Platelet-derived extracellular vesicles released after trauma promote hemostasis and contribute to DVT in mice. (Dyer MR, Alexander W, Hassoune A, Chen Q, Brzoska T, Alvikas J, Liu Y, Haldeman S, Plautz W, Loughran P, Li H, Boone B, Sadovsky Y, Sundd P, Zuckerbraun BS, Neal MD) J Thromb Haemost 2019 Oct;17(10):1733-1745 75 Citations |
| 1 | Factor VIII prophylaxis effects outweigh other hemostasis contributors in predicting severe haemophilia A joint outcomes. (Warren BB, Jacobson L, Kempton C, Buchanan GR, Recht M, Brown D, Leissinger C, Shapiro AD, Abshire TC, Manco-Johnson MJ, Joint Outcome Study Group Investigators) Haemophilia 2019 Sep;25(5):867-875 7 Citations |
| 2 | Diacylglycerol kinase ζ is a negative regulator of GPVI-mediated platelet activation. (Moroi AJ, Zwifelhofer NM, Riese MJ, Newman DK, Newman PJ) Blood Adv 2019 Apr 09;3(7):1154-1166 9 Citations |
| 2 | The impact of GPIbα on platelet-targeted FVIII gene therapy in hemophilia A mice with pre-existing anti-FVIII immunity. (Chen J, Schroeder JA, Luo X, Montgomery RR, Shi Q) J Thromb Haemost 2019 Mar;17(3):449-459 18 Citations |
| 1 | Defective collagen binding and increased bleeding in a murine model of von Willebrand disease affecting collagen IV binding. (Slobodianuk TL, Kochelek C, Foeckler J, Kalloway S, Weiler H, Flood VH) J Thromb Haemost 2019 Jan;17(1):63-71 14 Citations |
| 2 | Hemizygosity for the gene encoding glycoprotein Ibβ is not responsible for macrothrombocytopenia and bleeding in patients with 22q11 deletion syndrome. (Zwifelhofer NMJ, Bercovitz RS, Weik LA, Moroi A, LaRose S, Newman PJ, Newman DK) J Thromb Haemost 2019 Feb;17(2):295-305 11 Citations |
| 2 | Humanized GPIbα-von Willebrand factor interaction in the mouse. (Kanaji S, Orje JN, Kanaji T, Kamikubo Y, Morodomi Y, Chen Y, Zarpellon A, Eberhardt J, Forli S, Fahs SA, Sood R, Haberichter SL, Montgomery RR, Ruggeri ZM) Blood Adv 2018 Oct 09;2(19):2522-2532 16 Citations |
| 1 | Intravenous administration of synthetic platelets (SynthoPlate) in a mouse liver injury model of uncontrolled hemorrhage improves hemostasis. (Dyer MR, Hickman D, Luc N, Haldeman S, Loughran P, Pawlowski C, Sen Gupta A, Neal MD) J Trauma Acute Care Surg 2018 Jun;84(6):917-923 45 Citations |
| 1 | Pediatric issues in thrombosis and hemostasis: The how and why of venous thromboembolism risk stratification in hospitalized children. (Branchford BR, Betensky M, Goldenberg NA) Thromb Res 2018 Dec;172:190-193 25 Citations |
| 1 | Intravenous synthetic platelet (SynthoPlate) nanoconstructs reduce bleeding and improve 'golden hour' survival in a porcine model of traumatic arterial hemorrhage. (Hickman DA, Pawlowski CL, Shevitz A, Luc NF, Kim A, Girish A, Marks J, Ganjoo S, Huang S, Niedoba E, Sekhon UDS, Sun M, Dyer M, Neal MD, Kashyap VS, Sen Gupta A) Sci Rep 2018 Feb 15;8(1):3118 83 Citations |
| 1 | International comparative field study evaluating the assay performance of AFSTYLA in plasma samples at clinical hemostasis laboratories. (St Ledger K, Feussner A, Kalina U, Horn C, Metzner HJ, Bensen-Kennedy D, Blackman N, Veldman A, Stowers A, Friedman KD) J Thromb Haemost 2018 Mar;16(3):555-564 38 Citations |
| 1 | Viscoelastic Testing in Trauma. (Wirtz MR, Baumann HM, Klinkspoor JH, Goslings JC, Juffermans NP) Semin Thromb Hemost 2017 Jun;43(4):375-385 21 Citations |
| 1 | In vitro characterization of SynthoPlate™ (synthetic platelet) technology and its in vivo evaluation in severely thrombocytopenic mice. (Shukla M, Sekhon UD, Betapudi V, Li W, Hickman DA, Pawlowski CL, Dyer MR, Neal MD, McCrae KR, Sen Gupta A) J Thromb Haemost 2017 Feb;15(2):375-387 63 Citations |
| 2 | Targeting factor VIII expression to platelets for hemophilia A gene therapy does not induce an apparent thrombotic risk in mice. (Baumgartner CK, Mattson JG, Weiler H, Shi Q, Montgomery RR) J Thromb Haemost 2017 Jan;15(1):98-109 22 Citations |
| 1 | Thrombolysis by chemically modified coagulation factor Xa. (Pryzdial EL, Meixner SC, Talbot K, Eltringham-Smith LJ, Baylis JR, Lee FM, Kastrup CJ, Sheffield WP) J Thromb Haemost 2016 Sep;14(9):1844-54 7 Citations |
| 1 | Mechanical circulatory support: balancing bleeding and clotting in high-risk patients. (Baumann Kreuziger L, Massicotte MP) Hematology Am Soc Hematol Educ Program 2015;2015:61-8 45 Citations |
| 1 | Platelet-derived VWF in the stroke spotlight. (Flood VH) Blood 2015 Oct 01;126(14):1640-1 2 Citations |
| 1 | Victor J. Marder, M.D.: physician, scientist, founder, lover of the arts, teacher, leader (1934-2015). (White GC 2nd, Francis CW) J Thromb Haemost 2015 Jul;13(7):1354-7 |
| 1 | Microfluidic technology as an emerging clinical tool to evaluate thrombosis and hemostasis. (Branchford BR, Ng CJ, Neeves KB, Di Paola J) Thromb Res 2015 Jul;136(1):13-9 66 Citations |
| 1 | Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. (Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, del Junco DJ, Brasel KJ, Bulger EM, Callcut RA, Cohen MJ, Cotton BA, Fabian TC, Inaba K, Kerby JD, Muskat P, O'Keeffe T, Rizoli S, Robinson BR, Scalea TM, Schreiber MA, Stein DM, Weinberg JA, Callum JL, Hess JR, Matijevic N, Miller CN, Pittet JF, Hoyt DB, Pearson GD, Leroux B, van Belle G, PROPPR Study Group) JAMA 2015 Feb 03;313(5):471-82 2224 Citations |
| 1 | The impact of gender and left atrial blood stasis on adiponectin levels in non-valvular atrial fibrillation. (Cohoon KP, Mazur M, McBane RD, Ketha S, Ammash N, Wysokinski WE) Int J Cardiol 2015 Feb 15;181:207-12 9 Citations |
| 1 | Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial: design, rationale and implementation. (Baraniuk S, Tilley BC, del Junco DJ, Fox EE, van Belle G, Wade CE, Podbielski JM, Beeler AM, Hess JR, Bulger EM, Schreiber MA, Inaba K, Fabian TC, Kerby JD, Cohen MJ, Miller CN, Rizoli S, Scalea TM, O'Keeffe T, Brasel KJ, Cotton BA, Muskat P, Holcomb JB, PROPPR Study Group) Injury 2014 Sep;45(9):1287-95 133 Citations |
| 1 | The partial thromboplastin time. (Blatt PM, White GC 2nd) J Thromb Haemost 2014 Apr;12(4):574 2 Citations |
| 4 | Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A. (Du LM, Nurden P, Nurden AT, Nichols TC, Bellinger DA, Jensen ES, Haberichter SL, Merricks E, Raymer RA, Fang J, Koukouritaki SB, Jacobi PM, Hawkins TB, Cornetta K, Shi Q, Wilcox DA) Nat Commun 2013;4:2773 104 Citations |
| 1 | Platelet gene therapy by lentiviral gene delivery to hematopoietic stem cells restores hemostasis and induces humoral immune tolerance in FIX(null) mice. (Chen Y, Schroeder JA, Kuether EL, Zhang G, Shi Q) Mol Ther 2014 Jan;22(1):169-77 54 Citations |
| 1 | Kindlin-2 regulates hemostasis by controlling endothelial cell-surface expression of ADP/AMP catabolic enzymes via a clathrin-dependent mechanism. (Pluskota E, Ma Y, Bledzka KM, Bialkowska K, Soloviev DA, Szpak D, Podrez EA, Fox PL, Hazen SL, Dowling JJ, Ma YQ, Plow EF) Blood 2013 Oct 03;122(14):2491-9 39 Citations |
| 3 | Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo. (Zhi H, Rauova L, Hayes V, Gao C, Boylan B, Newman DK, McKenzie SE, Cooley BC, Poncz M, Newman PJ) Blood 2013 Mar 07;121(10):1858-67 89 Citations |
| 1 | Making a diagnosis of VWD. (Branchford BR, Di Paola J) Hematology Am Soc Hematol Educ Program 2012;2012:161-7 27 Citations |
| 2 | Contribution of platelet vs. endothelial VWF to platelet adhesion and hemostasis. (Kanaji S, Fahs SA, Shi Q, Haberichter SL, Montgomery RR) J Thromb Haemost 2012 Aug;10(8):1646-52 118 Citations |
| 2 | Platelet and endothelial expression of clotting factors for the treatment of hemophilia. (Montgomery RR, Shi Q) Thromb Res 2012 May;129 Suppl 2(Suppl 2):S46-8 16 Citations |
| 1 | Multimodal endovascular reperfusion therapies: adjunctive antithrombotic agents in acute stroke. (Lazzaro MA, Zaidat OO) Neurology 2012 Feb 14;78(7):501-6 6 Citations |
| 3 | Platelet gene therapy improves hemostatic function for integrin alphaIIbbeta3-deficient dogs. (Fang J, Jensen ES, Boudreaux MK, Du LM, Hawkins TB, Koukouritaki SB, Cornetta K, Wilcox DA) Proc Natl Acad Sci U S A 2011 Jun 07;108(23):9583-8 52 Citations |
| 2 | Novel clearance mechanisms of platelets. (Grozovsky R, Hoffmeister KM, Falet H) Curr Opin Hematol 2010 Nov;17(6):585-9 106 Citations |
| 1 | Mechanisms of cell signaling by the scavenger receptor CD36: implications in atherosclerosis and thrombosis. (Silverstein RL, Li W, Park YM, Rahaman SO) Trans Am Clin Climatol Assoc 2010;121:206-20 157 Citations |
| 2 | Platelets as delivery systems for disease treatments. (Shi Q, Montgomery RR) Adv Drug Deliv Rev 2010 Sep 30;62(12):1196-203 55 Citations |
| 2 | Targeting FVIII expression to endothelial cells regenerates a releasable pool of FVIII and restores hemostasis in a mouse model of hemophilia A. (Shi Q, Fahs SA, Kuether EL, Cooley BC, Weiler H, Montgomery RR) Blood 2010 Oct 21;116(16):3049-57 45 Citations |
| 1 | Hematological issues in critically ill patients with cancer. (Carlson KS, DeSancho MT) Crit Care Clin 2010 Jan;26(1):107-32 17 Citations |
| 2 | Phosphatidylethanolamine at the luminal endothelial surface--implications for hemostasis and thrombotic autoimmunity. (Zhixin Li, Wells CW, North PE, Kumar S, Duris CB, McIntyre JA, Ming Zhao) Clin Appl Thromb Hemost 2011 Apr;17(2):158-63 26 Citations |
| 3 | Syngeneic transplantation of hematopoietic stem cells that are genetically modified to express factor VIII in platelets restores hemostasis to hemophilia A mice with preexisting FVIII immunity. (Shi Q, Fahs SA, Wilcox DA, Kuether EL, Morateck PA, Mareno N, Weiler H, Montgomery RR) Blood 2008 Oct 01;112(7):2713-21 89 Citations |
| 1 | Using chemistry and microfluidics to understand the spatial dynamics of complex biological networks. (Kastrup CJ, Runyon MK, Lucchetta EM, Price JM, Ismagilov RF) Acc Chem Res 2008 Apr;41(4):549-58 22 Citations |
| 1 | Platelet secretion: indiscriminately spewed forth or highly orchestrated? (White GC 2nd, Rompietti R) J Thromb Haemost 2007 Oct;5(10):2006-8 35 Citations |
| 1 | Characterization of the threshold response of initiation of blood clotting to stimulus patch size. (Kastrup CJ, Shen F, Runyon MK, Ismagilov RF) Biophys J 2007 Oct 15;93(8):2969-77 42 Citations |
| 1 | Propagation of blood clotting in the complex biochemical network of hemostasis is described by a simple mechanism. (Runyon MK, Johnson-Kerner BL, Kastrup CJ, Van Ha TG, Ismagilov RF) J Am Chem Soc 2007 Jun 06;129(22):7014-5 39 Citations |
| 3 | Homeostatic expansion and repertoire regeneration of donor T cells during graft versus host disease is constrained by the host environment. (Gorski J, Chen X, Gendelman M, Yassai M, Krueger A, Tivol E, Logan B, Komorowski R, Vodanovic-Jankovic S, Drobyski WR) Blood 2007 Jun 15;109(12):5502-10 16 Citations |
| 1 | Modular chemical mechanism predicts spatiotemporal dynamics of initiation in the complex network of hemostasis. (Kastrup CJ, Runyon MK, Shen F, Ismagilov RF) Proc Natl Acad Sci U S A 2006 Oct 24;103(43):15747-52 70 Citations |
| 3 | Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies. (Shi Q, Wilcox DA, Fahs SA, Weiler H, Wells CW, Cooley BC, Desai D, Morateck PA, Gorski J, Montgomery RR) J Clin Invest 2006 Jul;116(7):1974-82 164 Citations |
| 1 | A novel mechanism for regulation of retinal blood flow by lactate: gap junctions, hypoxia, and pericytes. (Lombard JH) Am J Physiol Heart Circ Physiol 2006 Mar;290(3):H921-2 10 Citations |
| 1 | Congenital and acquired platelet disorders: current dilemmas and treatment strategies. (White GC 2nd) Semin Hematol 2006 Jan;43(1 Suppl 1):S37-41 25 Citations |
| 2 | Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells. (Sood R, Kalloway S, Mast AE, Hillard CJ, Weiler H) Blood 2006 Apr 15;107(8):3173-80 90 Citations |
| 1 | Mitogen-activated protein kinase activation and regulation in the pressure-loaded fetal ovine heart. (Olson AK, Protheroe KN, Segar JL, Scholz TD) Am J Physiol Heart Circ Physiol 2006 Apr;290(4):H1587-95 15 Citations |
| 2 | Rap1b is required for normal platelet function and hemostasis in mice. (Chrzanowska-Wodnicka M, Smyth SS, Schoenwaelder SM, Fischer TH, White GC 2nd) J Clin Invest 2005 Mar;115(3):680-7 282 Citations |
| 1 | Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets. (Bergmeier W, Burger PC, Piffath CL, Hoffmeister KM, Hartwig JH, Nieswandt B, Wagner DD) Blood 2003 Dec 01;102(12):4229-35 154 Citations |
| 2 | Mechanisms and implications of platelet discoid shape. (Italiano JE Jr, Bergmeier W, Tiwari S, Falet H, Hartwig JH, Hoffmeister KM, André P, Wagner DD, Shivdasani RA) Blood 2003 Jun 15;101(12):4789-96 147 Citations |
| 1 | A reference system approach to future standardization of laboratory tests for hemostasis. A position paper of the Joint Committee of the IFCC Scientific Division and the ISTH Scientific and Standardization Committee. (Jackson CM, White GC 2nd, Barrowcliffe T, Esnouf MP, Jespersen J, Kluft C, Lenahan J, Joint Committee of the IFCC Scientific Division and the ISTH Scientific and Standardization Committee) Thromb Haemost 2002 Jan;87(1):165-9 14 Citations |
| 2 | Mechanisms of cold-induced platelet actin assembly. (Hoffmeister KM, Falet H, Toker A, Barkalow KL, Stossel TP, Hartwig JH) J Biol Chem 2001 Jul 06;276(27):24751-9 90 Citations |
| 1 | Utilization of previously treated patients (PTPs), noninfected patients (NIPs), and previously untreated patients (PUPs) in the evaluation of new factor VIII and factor IX concentrates. Recommendation of the Scientific Subcommittee on Factor VIII and Factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. (White GC, DiMichele D, Mertens K, Negrier C, Peake IR, Prowse C, Schwaab R, Yoshioka A, Ingerslev J) Thromb Haemost 1999 Mar;81(3):462 61 Citations |
| 1 | Safety of high doses of a monoclonal antibody-purified factor IX concentrate. The Mononine Study Group. (Warrier I, Kasper CK, White GC 2nd, Shapiro AD, Bergman GE) Am J Hematol 1995 May;49(1):92-4 7 Citations |
| 1 | Principles of thromboregulation: control of platelet reactivity in vascular disease. (Marcus AJ, Safier LB, Kaminski WE, Islam N, Hajjar KA, Jendraschak E, Silverstein RL, Broekman MJ, von Schacky C, Fliessbach JH) Adv Prostaglandin Thromboxane Leukot Res 1995;23:413-8 9 Citations |
| 1 | Relative antithrombotic effects of monoclonal antibodies targeting different platelet glycoprotein-adhesive molecule interactions in nonhuman primates. (Cadroy Y, Hanson SR, Kelly AB, Marzec UM, Evatt BL, Kunicki TJ, Montgomery RR, Harker LA) Blood 1994 Jun 01;83(11):3218-24 70 Citations |
| 1 | The use of continuous infusion of factor concentrates in the treatment of hemophilia. (Bona RD, Weinstein RA, Weisman SJ, Bartolomeo A, Rickles FR) Am J Hematol 1989 Sep;32(1):8-13 64 Citations |
| 1 | Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon. (Hanson SR, Pareti FI, Ruggeri ZM, Marzec UM, Kunicki TJ, Montgomery RR, Zimmerman TS, Harker LA) J Clin Invest 1988 Jan;81(1):149-58 135 Citations |
| 1 | Evidence that platelet buoyant density, but not size, correlates with platelet age in man. (Mezzano D, Hwang K, Catalano P, Aster RH) Am J Hematol 1981;11(1):61-76 64 Citations |
| 1 | Relative hemostatic effectiveness of human platelets stored at 4 degrees and 22 degrees C. (Filip DJ, Aster RH) J Lab Clin Med 1978 Apr;91(4):618-24 147 Citations |
| 1 | Studies to improve methods of short-term platelet preservation. (Aster RH, Becker GA, Filip DJ) Transfusion 1976;16(1):4-7 11 Citations |
| 1 | Platelet function: its clinical significance. (Ginsburg AD, Aster RH) Dis Mon 1970 Sep:2-42 1 Citation |
